{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:09:09Z","timestamp":1792613349232,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.cmi.2020.04.018","type":"journal-article","created":{"date-parts":[[2020,4,29]],"date-time":"2020-04-29T14:02:18Z","timestamp":1588168938000},"page":"443-450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":95,"title":["Highly sensitive and specific detection of hepatitis B virus DNA and drug resistance mutations utilizing the PCR-based CRISPR-Cas13a system"],"prefix":"10.1016","volume":"27","author":[{"given":"S.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Kou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2020.04.018_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jhep.2009.04.003","article-title":"Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia","volume":"51","author":"Liaw","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cmi.2020.04.018_bib2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/s12879-017-2765-2","article-title":"WHO guidelines on testing for hepatitis B and C \u2013 meeting targets for testing","volume":"17","author":"Hellard","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.cmi.2020.04.018_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/j.1537-2995.2009.02343.x","article-title":"Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain","volume":"50","author":"Gonzalez","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.cmi.2020.04.018_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tracli.2003.11.007","article-title":"Occult hepatitis B virus infection","volume":"11","author":"Allain","year":"2004","journal-title":"Transfus Clin Biol"},{"key":"10.1016\/j.cmi.2020.04.018_bib5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1440-1746.2010.06492.x","article-title":"Poor durability of lamivudine effectiveness despite stringent cessation criteria: a prospective clinical study in hepatitis B e antigen-negative chronic hepatitis B patients","volume":"26","author":"Liu","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cmi.2020.04.018_bib6","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1537-2995.2009.02357.x","article-title":"The efficacy of individual-donation and minipool testing to detect low-level hepatitis B virus DNA in Taiwan","volume":"50","author":"Yang","year":"2010","journal-title":"Transfusion"},{"key":"10.1016\/j.cmi.2020.04.018_bib7","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1128\/JCM.00914-06","article-title":"COBAS AmpliPrep-COBAS TaqMan hepatitis B virus (HBV) test: a novel automated real-time PCR assay for quantification of HBV DNA in plasma","volume":"45","author":"Allice","year":"2007","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2020.04.018_bib8","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1478-3231.2008.01939.x","article-title":"Management and prevention of drug resistance in chronic hepatitis B","volume":"29","author":"Zoulim","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.cmi.2020.04.018_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cmi.2020.04.018_bib10","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/hep.27889","article-title":"Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load","volume":"62","author":"Sinn","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.cmi.2020.04.018_bib11","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1136\/gut.52.12.1779","article-title":"Quantitative polymerase chain reaction assay for serum hepatitis B virus DNA as a predictive factor for post-treatment relapse after lamivudine induced hepatitis B e antigen loss or seroconversion","volume":"52","author":"Lee","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.cmi.2020.04.018_bib12","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1002\/hep.1840360617","article-title":"Quantitative serum HBV DNA levels during different stages of chronic hepatitis B infection","volume":"36","author":"Chu","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cmi.2020.04.018_bib13","doi-asserted-by":"crossref","first-page":"11954","DOI":"10.3748\/wjg.v21.i42.11954","article-title":"Rapid and quantitative detection of hepatitis B virus","volume":"21","author":"Liu","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cmi.2020.04.018_bib14","first-page":"1","article-title":"Comparison of droplet digital PCR to real-time PCR for quantification of hepatitis B virus DNA","author":"Tang","year":"2016","journal-title":"Biosci Biotechnol Biochem"},{"key":"10.1016\/j.cmi.2020.04.018_bib15","doi-asserted-by":"crossref","first-page":"aaf5573","DOI":"10.1126\/science.aaf5573","article-title":"C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector","volume":"353","author":"Abudayyeh","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.cmi.2020.04.018_bib16","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/nature19802","article-title":"Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection","volume":"538","author":"East-Seletsky","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.cmi.2020.04.018_bib17","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.aam9321","article-title":"Nucleic acid detection with CRISPR-Cas13a\/C2c2","volume":"356","author":"Gootenberg","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.cmi.2020.04.018_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1373\/clinchem.2014.230227","article-title":"Next generation digital PCR measurement of hepatitis B virus copy number in formalin-fixed paraffin-embedded hepatocellular carcinoma tissue","volume":"61","author":"Huang","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.cmi.2020.04.018_bib19","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/jgh.12831","article-title":"Incidence of natural resistance mutations in naive chronic hepatitis B patients: a systematic review and meta-analysis","volume":"30","author":"Zhang","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.cmi.2020.04.018_bib20","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/infdis\/jiv363","article-title":"Combined analysis of the prevalence of drug-resistant hepatitis B virus in antiviral therapy-experienced patients in Europe (CAPRE)","volume":"213","author":"Hermans","year":"2016","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2020.04.018_bib21","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jviromet.2007.07.005","article-title":"Comparison of versant HBV DNA 3.0 and COBAS AmpliPrep-COBAS TaqMan assays for hepatitis B DNA quantitation: possible clinical implications","volume":"146","author":"Garbuglia","year":"2007","journal-title":"J\u00a0Virol Meth"},{"key":"10.1016\/j.cmi.2020.04.018_bib22","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2036.2011.04738.x","article-title":"Predictors of relapse in chronic hepatitis B after discontinuation of anti-viral therapy","volume":"34","author":"Liang","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cmi.2020.04.018_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.cmi.2020.04.018_bib24","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/nmeth.2633","article-title":"Absolute quantification by droplet digital PCR versus analog real-time PCR","volume":"10","author":"Hindson","year":"2013","journal-title":"Nat Methods"},{"key":"10.1016\/j.cmi.2020.04.018_bib25","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.3748\/wjg.v21.i7.2089","article-title":"Natural YMDD-motif mutants affect clinical course of lamivudine in chronic hepatitis B","volume":"21","author":"Tan","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.cmi.2020.04.018_bib26","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.3748\/wjg.v23.i23.4222","article-title":"Naturally occurring mutations in the reverse transcriptase region of hepatitis B virus polymerase from treatment-naive Korean patients infected with genotype C2","volume":"23","author":"Kim","year":"2017","journal-title":"World J Gastroenterol"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20302263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X20302263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:28:22Z","timestamp":1761118102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X20302263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S1198743X20302263"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2020.04.018","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Highly sensitive and specific detection of hepatitis B virus DNA and drug resistance mutations utilizing the PCR-based CRISPR-Cas13a system","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2020.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}